The present results suggested that circRNA_CER may serve an important role in the progression of breast cancer by regulating the activity of the miR_136/MMP13 axis, and may be a potential biomarker for the prediction and treatment of breast cancer.
circRNA_CER mediates malignant progression of breast cancer through targeting the miR_136/MMP13 axis.